Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Troy E. Wilson, PhD, J.D.$1.4B
Market Cap • 24/04/20242007
(há 17 anos)
2015
(9 years ago)
NASDAQ
Listagem
San Diego
Sede • California133
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
KURASó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.